Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.23B |
| 2 |
Salesforce
CRM
|
+$777M |
| 3 |
Flutter Entertainment
FLUT
|
+$622M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$569M |
| 5 |
Amazon
AMZN
|
+$566M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$1.95B |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
+$738M |
| 3 |
Alibaba
BABA
|
+$328M |
| 4 |
Vistra
VST
|
+$313M |
| 5 |
Wells Fargo
WFC
|
+$265M |
Sector Composition
| 1 | Technology | 25.45% |
| 2 | Financials | 12.86% |
| 3 | Industrials | 11.53% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Healthcare | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Capricor Therapeutics
CAPR
$290M
| $203K | ﹤0.01% |
14,678
+2,500
| +21% | +$34.5K |
|
3402
Outdoor Holding Company Common Stock
POWW
$169M
| $202K | ﹤0.01% |
183,953
+2,536
| +1% | +$2.79K |
|
3403
Evolus
EOLS
$492M
| $202K | ﹤0.01% |
18,326
-83,072
| -82% | -$917K |
|
|
PEO
3404
Adams Natural Resources Fund
PEO
$575M
| $202K | ﹤0.01% |
9,305
-147
| -2% | -$3.2K |
|
|
API
3405
Agora
API
$334M
| $202K | ﹤0.01% |
48,619
-434
| -0.9% | -$1.81K |
|
|
MAGN
3406
Magnera Corporation
MAGN
$420M
| $201K | ﹤0.01% |
+11,088
| New | +$201K |
|
3407
Purple Innovation
PRPL
$118M
| $201K | ﹤0.01% |
257,277
-36,814
| -13% | -$28.7K |
|
3408
Bioventus
BVS
$482M
| $201K | ﹤0.01% |
19,096
-323,850
| -94% | -$3.4M |
|
3409
CorMedix
CRMD
$952M
| $200K | ﹤0.01% |
24,703
+3,784
| +18% | +$30.7K |
|
3410
Keros Therapeutics
KROS
$628M
| $200K | ﹤0.01% |
12,616
+453
| +4% | +$7.17K |
|
3411
Entrada Therapeutics
TRDA
$201M
| $199K | ﹤0.01% |
+11,504
| New | +$199K |
|
|
GUG
3412
Guggenheim Active Allocation Fund
GUG
$528M
| $197K | ﹤0.01% |
+13,247
| New | +$197K |
|
|
CHW
3413
Calamos Global Dynamic Income Fund
CHW
$465M
| $197K | ﹤0.01% |
+29,170
| New | +$197K |
|
|
ZTR
3414
Virtus Total Return Fund
ZTR
$346M
| $197K | ﹤0.01% |
+33,562
| New | +$197K |
|
|
NVRO
3415
DELISTED
NEVRO CORP.
NVRO
| $197K | ﹤0.01% |
52,844
+1,184
| +2% | +$4.4K |
|
3416
Oric Pharmaceuticals
ORIC
$1.02B
| $193K | ﹤0.01% |
23,958
+1,876
| +8% | +$15.1K |
|
|
RVNC
3417
DELISTED
Revance Therapeutics, Inc.
RVNC
| $193K | ﹤0.01% |
63,537
+7,125
| +13% | +$21.7K |
|
3418
Semrush
SEMR
$1.16B
| $191K | ﹤0.01% |
16,075
-7,048
| -30% | -$83.7K |
|
3419
CarParts.com
PRTS
$58.5M
| $191K | ﹤0.01% |
176,529
-1,158
| -0.7% | -$1.25K |
|
3420
Talkspace
TALK
$447M
| $189K | ﹤0.01% |
61,055
-22,303
| -27% | -$68.9K |
|
3421
Couchbase
BASE
$1.35B
| $187K | ﹤0.01% |
11,966
-2,739
| -19% | -$42.7K |
|
3422
Banco Santander
SAN
$145B
| $185K | ﹤0.01% |
40,599
+497
| +1% | +$2.27K |
|
3423
Melco Resorts & Entertainment
MLCO
$3.75B
| $184K | ﹤0.01% |
31,745
+21,707
| +216% | +$126K |
|
|
PPTA
3424
Perpetua Resources
PPTA
$1.94B
| $183K | ﹤0.01% |
17,153
+331
| +2% | +$3.53K |
|
3425
Evolv Technologies
EVLV
$1.42B
| $182K | ﹤0.01% |
46,069
+1,335
| +3% | +$5.27K |
|